Literature DB >> 680410

Glycosylated hemoglobin in normal subjects and subjects with maturity-onset diabetes. Evidence for a saturable system in man.

R J Graf, J B Halter, D Porte.   

Abstract

Concentrations of glycosylated hemoglobin (GHb) are elevated in diabetes mellitus and are believed to reflect previous metabolic control. To better define possible determinants of GHb in man, we investigated the relationship between GHb and both fasting plasma glucose (FPG) and basal insulin (IRI) in 42 normal subjects and 29 patients with maturity-onset diabetes. Concentrations of GHb in diabetic subjects (12.7 +/- 3.4, x +/- S.D., per cent total hemoglobin) were significantly higher than in normal subjects (8.2 +/- 1.2, p less than 0.001). In normal subjects, FPG (r = 0.52) and GHb (r = 0.58) (both p less than 0.001) correlated with age. GHb did not correlate with IRI in either group. However, GHb was closely associated with FPG in both normal (r = 0.60, p less than 0.001) and diabetic (r = 0.85, p less than 0.001) subjects. Linear regression analysis of the data for the two groups combined was highly significant (r = 0.91, p less than 0.001). However, the slope of the regression line for GHb versus FPG seen in normal subjects was significantly steeper than that of diabetic patients (p less than 0.005). A curve describing a nonenzymatic saturable model was also found to fit the data of the two groups combined (r = 0.85, p less than 0.001), suggesting the possible existence of a saturable system for glycosylation in man.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 680410     DOI: 10.2337/diab.27.8.834

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  24 in total

1.  Metabolic control, glycosylated haemoglobin and high density lipoprotein cholesterol in diabetic children.

Authors:  L Klujber; D Molnár; M Kardos; V Jászai; G Soltész; J Mestyán
Journal:  Eur J Pediatr       Date:  1979       Impact factor: 3.183

2.  Characterization of glycosylated hemoglobins. Relevance to monitoring of diabetic control and analysis of other proteins.

Authors:  R L Garlick; J S Mazer; P J Higgins; H F Bunn
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

Review 3.  Glycosylated haemoglobin: measurement and clinical use.

Authors:  I Peacock
Journal:  J Clin Pathol       Date:  1984-08       Impact factor: 3.411

4.  Glycosylated haemoglobin in renal failure.

Authors:  M J de Boer; K Miedema; A F Casparie
Journal:  Diabetologia       Date:  1980-06       Impact factor: 10.122

5.  Serum fructosamine concentrations in patients with type II (non-insulin-dependent) diabetes mellitus during changes in management.

Authors:  J R Baker; R N Johnson; D J Scott
Journal:  Br Med J (Clin Res Ed)       Date:  1984-05-19

6.  Biochemical predictors of short term mortality in elderly residents of chronic care institutions.

Authors:  J Woo; S M Chan; Y T Mak; R Swaminathan
Journal:  J Clin Pathol       Date:  1989-12       Impact factor: 3.411

7.  Markers of glycemic control in the mouse: comparisons of 6-h- and overnight-fasted blood glucoses to Hb A1c.

Authors:  Byoung Geun Han; Chuan-Ming Hao; Elena E Tchekneva; Ying-Ying Wang; Chieh Allen Lee; Benyamin Ebrahim; Raymond C Harris; Timothy S Kern; David H Wasserman; Matthew D Breyer; Zhonghua Qi
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-07-29       Impact factor: 4.310

8.  Non-enzymatic glycation of epidermal proteins of the stratum corneum in diabetic patients.

Authors:  I Márová; J Záhejský; H Sehnalová
Journal:  Acta Diabetol       Date:  1995-03       Impact factor: 4.280

9.  Home blood glucose concentrations in maturity-onset diabetes.

Authors:  R B Paisey; P Bradshaw; M Hartog
Journal:  Br Med J       Date:  1980-03-01

10.  Changes in glycosylated haemoglobin after poor control in insulin-dependent diabetics.

Authors:  A P Brooks; I M Nairn; J D Baird
Journal:  Br Med J       Date:  1980-09-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.